Buy Sustiva
Sustiva

$3.87
Category
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Sustiva Properties

Active Ingredients
Primary Category
Pharmacological Class
NNRTI
Indications
Dosage Forms
Capsules, Tablets
Administration Route
Oral
Mechanism of Action
Works by blocking an enzyme that HIV needs to multiply in the body, which helps control the infection.
Prescription Status
Rx
Manufacturer
Bristol-Myers Squibb
Patient Summary
An antiviral medication used as part of a combination therapy to treat HIV-1 infection.
Onset Time
Steady state levels achieved within 7 days
Duration
Around 40-52 hours
Storage Instructions
Store at room temperature
Age Restrictions
Approved for use in children aged 3 months and older, adolescents, and adults.
Pregnancy Use
Not recommended for use during the first trimester of pregnancy due to risk of birth defects. Consult doctor before use while breastfeeding.
Alternative Drugs

About Sustiva

Generic Sustiva (Efavirenz) is a branded formulation of the non-nucleoside reverse transcriptase inhibitor efavirenz, approved in Australia for the treatment of HIV-1 infection in combination with other antiretroviral agents. It is supplied as oral tablets in 200 mg and 600 mg strengths, designed to suppress viral replication and improve immune function. While its primary indication is for adults living with HIV/AIDS, clinicians may also prescribe it for certain paediatric cases under specialist guidance. The medication is taken once daily, usually on an empty stomach, to maintain steady plasma concentrations that keep the virus at bay.

What is Generic Sustiva (Efavirenz)?

Generic Sustiva (Efavirenz) belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs). It received approval from the Therapeutic Goods Administration (TGA) in 2002 and is listed on the Australian Register of Therapeutic Goods (ARTG). As a generic product, it contains the same active ingredient, dosage forms, and bioavailability as the original brand, offering a cost-effective alternative without compromising efficacy. The tablets are intended for use as part of a combination antiretroviral regimen, typically alongside two nucleoside reverse transcriptase inhibitors (NRTIs).

How Sustiva Works

Efavirenz binds directly to the HIV-1 reverse transcriptase enzyme at a site distinct from the nucleoside substrate. This allosteric interaction induces a conformational change that blocks the enzyme’s ability to convert viral RNA into DNA, halting the integration of the virus into host cells. Because the drug does not require intracellular phosphorylation, it achieves rapid inhibition after absorption.

Pharmacokinetic highlights:

  • Absorption: Peak plasma levels appear within 3-5 hours when taken on an empty stomach; food, especially high-fat meals, can reduce exposure by up to 30 %.
  • Distribution: Efavirenz is highly lipophilic, resulting in extensive tissue penetration and a large volume of distribution.
  • Metabolism: Primarily metabolised by hepatic CYP2B6, with contributions from CYP3A4 and CYP2A6. Genetic polymorphisms in CYP2B6 can markedly affect plasma concentrations.
  • Elimination: The terminal half-life ranges from 40 to 55 hours, supporting once-daily dosing.
  • Excretion: Less than 5 % is eliminated unchanged in urine; most metabolites are excreted via the bile.

These properties create a sustained antiviral effect, allowing the drug to maintain viral suppression with a single daily tablet.

Why Sustiva Is Used for HIV/AIDS Conditions

  • Effective viral suppression: By directly inhibiting reverse transcriptase, efavirenz reduces plasma HIV-RNA to undetectable levels in the majority of patients when combined with two NRTIs.
  • Improved CD4⁺ counts: Consistent viral control permits immune recovery, reflected in rising CD4⁺ lymphocyte numbers and reduced opportunistic infections.
  • First-line guideline endorsement: The Australian HIV Treatment Guidelines list efavirenz-based regimens as a preferred option for treatment-naïve adults, especially when resistance testing shows susceptibility.
  • Convenient dosing: Once-daily administration enhances adherence compared with twice-daily regimens.
  • High barrier to resistance when combined: While efavirenz alone can select for resistance mutations, its use within a three-drug regimen limits the emergence of resistant strains.
  • Pediatric applicability: For children weighing ≥ 10 kg, the 200 mg tablet can be dose-adjusted, providing a flexible option under specialist supervision.

Is Sustiva Right for You?

Sustiva is most suitable for adults who are initiating antiretroviral therapy and have no contraindications to NNRTIs. Ideal candidates are those who can adhere to a once-daily schedule and can tolerate the drug’s central nervous system (CNS) side-effect profile. Special populations to consider:

  • Pregnancy: Efavirenz is classified as Category D in Australia; it is generally avoided during the first trimester due to potential teratogenicity, but may be continued later if benefits outweigh risks.
  • Elderly: Age-related hepatic changes may increase plasma levels; dose adjustment is rarely required but monitoring is prudent.
  • Renal or hepatic impairment: No dose reduction is needed for mild to moderate dysfunction, yet severe hepatic impairment warrants careful observation.
  • Co-administration with CYP inducers/inhibitors: Drugs such as rifampicin or certain antiepileptics can lower efavirenz concentrations, while potent CYP2B6 inhibitors may raise them, necessitating therapeutic drug monitoring.

Patients with a history of severe psychiatric illness should discuss risks with their clinician, as efavirenz can exacerbate mood disturbances.

Taking Sustiva Effectively

  • Timing: Swallow the tablet whole with a glass of water on an empty stomach-ideally 1 hour before or 2 hours after meals-to maximise absorption.
  • Missed dose: If a dose is forgotten and it is within 12 hours of the scheduled time, take it immediately; otherwise skip and resume the regular schedule. Do not double-dose.
  • Alcohol and caffeine: Moderate consumption is acceptable, but excessive intake may intensify CNS side effects.
  • Travel considerations: Carry a sufficient supply for the entire trip, as some regions may have limited access to antiretrovirals. Keep tablets in original packaging to avoid customs issues.
  • Adherence tools: Use daily alarms, pillboxes, or mobile apps to maintain consistency, which is critical for preventing viral rebound.

Understanding Side Effects and How to Manage Them

Efavirenz’s side-effect profile is closely linked to its CNS penetration and hepatic metabolism.

  • Common CNS effects (30-50 %): Dizziness, vivid dreams, insomnia, and impaired concentration. These usually emerge within the first two weeks and often diminish after 4-6 weeks. Strategies include taking the tablet at bedtime, maintaining a regular sleep schedule, and limiting stimulant use.
  • Rash: A mild maculopapular eruption may appear early; antihistamines can provide relief. Discontinue immediately if the rash progresses to Stevens-Johnson syndrome-seek urgent care.
  • Elevated liver enzymes: Routine monitoring of ALT/AST is recommended; transient rises are typically asymptomatic. Persistent elevations warrant evaluation for hepatitis co-infection.
  • Neuropsychiatric symptoms: Anxiety, depression, or suicidal ideation are rare but serious. Prompt psychiatric assessment is essential; dose reduction is not recommended, but switching to an alternative NNRTI may be necessary.
  • Lipodystrophy: Long-term therapy can alter fat distribution; lifestyle interventions and consultation with a metabolic specialist can mitigate impact.

Patients should contact their healthcare provider if side effects are severe, persistent, or interfere with daily activities.

Buying Sustiva from Our Online Pharmacy

Why Choose Our Service?

Accessing efavirenz can be challenging in remote Australian regions or for individuals without private health cover. Our online pharmacy bridges that gap, offering a discreet, reliable channel to obtain Sustiva at a price that respects your budget.

Quality & Safety

We partner with licensed Australian and international pharmacies that operate under strict regulatory oversight. All products are sourced from manufacturers that meet WHO Good Manufacturing Practice standards, ensuring each tablet matches the potency and purity of the original formulation.

Pricing & Access

Generic Sustiva is priced competitively, often 30 % lower than the branded counterpart. For repeat customers, we provide a lifetime 10 % discount on all reorders, making long-term therapy more affordable.

Discreet Delivery

Orders are packaged in unmarked, tamper-evident envelopes. Express shipping typically arrives within 7 days, while standard delivery takes up to 3 weeks, both with tracking to keep you informed.

Frequently Asked Questions

  • What should I do if I experience vivid dreams after starting Sustiva? Take the tablet at bedtime and avoid caffeine in the evening. Most patients notice improvement after the first month; if dreams remain disturbing, discuss a possible switch with your clinician.

  • Can Sustiva be taken with other antiretrovirals? Yes, it is intended to be part of a three-drug regimen, usually combined with two NRTIs such as tenofovir and emtricitabine. Your prescriber will select compatible partners.

  • Is it safe to use Sustiva while breastfeeding? Efavirenz is excreted in breast milk in low concentrations. Current guidelines advise against breastfeeding if the mother is on efavirenz, especially during the first six months postpartum.

  • How does efavirenz differ from other NNRTIs like rilpivirine? Efavirenz has a longer half-life and a well-established efficacy record, but it is more likely to cause CNS side effects. Rilpivirine may be preferred for patients with a history of neuropsychiatric intolerance.

  • Will my liver function tests need regular monitoring? Baseline ALT/AST assessment is recommended before initiating therapy, followed by periodic checks at 4-6 weeks and then every 3-6 months, or sooner if symptoms arise.

  • Can I split the 600 mg tablet to achieve a lower dose? The tablet is not scored and should be taken whole. Dose adjustments are made by selecting the appropriate strength rather than splitting tablets.

  • What happens if I miss several doses in a row? Contact your healthcare provider promptly. A brief interruption can lead to viral rebound and resistance; a clinician may advise a temporary switch to an alternative regimen.

  • Is there any interaction between Sustiva and over-the-counter supplements? St. John’s wort and certain herbal products induce CYP enzymes and can lower efavirenz levels, reducing effectiveness. Always disclose supplement use to your prescriber.

  • How long will I need to stay on Sustiva? Antiretroviral therapy is lifelong for most individuals with HIV. Ongoing viral suppression and immune recovery depend on continuous adherence.

  • Does Sustiva protect against other sexually transmitted infections? No. While it controls HIV replication, it does not prevent acquisition of other STIs; barrier methods and regular testing remain essential.

  • Can I travel internationally with my Sustiva prescription? Carry a copy of your prescription and a letter from your doctor stating the medical necessity. Some countries require documentation for importation of antiretrovirals.

Glossary

Reverse Transcriptase
An enzyme HIV uses to convert its RNA genome into DNA, a critical step for viral replication.
CYP2B6
A liver enzyme that metabolises efavirenz; genetic variations can alter drug levels.
Bioequivalence
Demonstrates that a generic product delivers the same amount of active ingredient into the bloodstream as the reference brand.
Stevens-Johnson Syndrome
A severe, life-threatening skin reaction that requires immediate medical attention.
Therapeutic Drug Monitoring
Measurement of drug concentrations in blood to ensure they remain within a target range for efficacy and safety.

Disclaimer

The information provided about Sustiva is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Sustiva for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Sustiva


Information Prepared By

Sarah Jones
Tosin (Olalekan) Olaluwoye, MD, PhD